Reducing the risk of recurrent preterm births using probiotics
Peer-Reviewed Publication
Updates every hour. Last Updated: 26-May-2026 12:16 ET (26-May-2026 16:16 GMT/UTC)
Preterm birth is a major cause of neonatal illness and death, especially among women with a history of premature delivery. Researchers in Japan explored whether taking probiotics early in pregnancy could help reduce the risk of spontaneous preterm delivery (sPTD). In a multicenter clinical trial, women who consumed probiotics containing Clostridium butyricum showed lower recurrence rates compared with national averages, suggesting that probiotic therapy may offer a simple strategy to help prevent premature births.
Immunoglobulin A (IgA) nephropathy results from the accumulation of IgA-containing immune complexes (IgA-ICs) and aberrant IgA antibodies in the glomerular mesangium. Now, researchers have found that complement pathway proteins are involved in the formation of these complexes. One such protein, complement factor H-related protein 1, is overexpressed in the glomeruli and IgA-ICs isolated from patients and could serve as a biomarker for disease susceptibility and progression, as well as a possible target for new therapies.
A doctoral thesis by Amal D. Premarathna shows that polysaccharides derived from algae have strong wound-healing, anti-inflammatory, and skin-protective properties. These findings highlight algae as a promising, sustainable alternative to synthetic treatments for chronic wounds and related health applications.
A new, more life-like physical model of microscopic nerve fibres called axons could speed up the discovery of medicines for multiple sclerosis and other degenerative brain diseases, suggests a new study led by University College London (UCL) researchers.